| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Epidemiology and Prevention |
Occupational Health Program, Departments of Environmental Health [W. Z., G. L., D. P. M., L. L. X., L. S., D. C. C.] and Biostatistics [S. W. T.], Harvard School of Public Health, Boston, Massachusetts 02115, and Department of Hematology-Oncology [G. L., T. J. L.], Pulmonary and Critical Care Unit [D. C. C.], Department of Medicine, and Thoracic Surgery Unit, Department of Surgery [J. C. W.], Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114
Excision repair cross-complementing group 2 (ERCC2), a major DNA repair protein, is involved in nucleotide excision repair and basal transcription. The ERCC2 polymorphisms have been associated with altered DNA repair capacity. We investigated two ERCC2 polymorphisms, Asp312Asn and Lys751Gln, in 1092 Caucasian lung cancer patients and 1240 spouse and friend controls. The results were analyzed using generalized additive models and logistic regression, adjusting for relevant covariates. The overall adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were 1.47 (95% CI, 1.1–2.0) for the Asp312Asn polymorphism (Asn/Asn versus Asp/Asp) and 1.06 (95% CI, 0.8–1.4) for the Lys751Gln polymorphism (Gln/Gln versus Lys/Lys). Gene-smoking interaction analyses revealed that the adjusted ORs for each of the two polymorphisms decreased significantly as pack-years increased. When comparing individuals with Asn/Asn + Gln/Gln versus individuals with Asp/Asp + Lys/Lys, the fitted ORs (95% CIs) were 2.56 (95% CI, 1.3–5.0) in nonsmokers and 0.69 (95% CI, 0.4–1.2) in heavy smokers (80 pack-years; P < 0.01 for the interaction term). Consistent and robust results were found when models incorporated different definitions of cumulative cigarette smoking. A stronger gene-smoking interaction was observed for the Asp312Asn polymorphism than for the Lys751Gln polymorphism. In conclusion, cumulative cigarette smoking modifies the associations between ERCC2 polymorphisms and lung cancer risk.
This article has been cited by other articles:
|
|
 |
|
  L. J. Chin, E. Ratner, S. Leng, R. Zhai, S. Nallur, I. Babar, R.-U. Muller, E. Straka, L. Su, E. A. Burki, et al. A SNP in a let-7 microRNA Complementary Site in the KRAS 3' Untranslated Region Increases Non-Small Cell Lung Cancer Risk Cancer Res., October 15, 2008; 68(20): 8535 - 8540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. McWilliams, W. R. Bamlet, J. M. Cunningham, E. L. Goode, M. de Andrade, L. A. Boardman, and G. M. Petersen Polymorphisms in DNA Repair Genes, Smoking, and Pancreatic Adenocarcinoma Risk Cancer Res., June 15, 2008; 68(12): 4928 - 4935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Wang, D. Chang, F.-l. Hu, H. Sui, B. Han, D.-d. li, and Y.-s. Zhao DNA Repair Gene XPD Polymorphisms and Cancer Risk: A Meta-analysis Based on 56 Case-Control Studies Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 507 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. McCarty, T. J. Smith, W. Zhou, E. Gonzalez, Q. Quamruzzaman, M. Rahman, G. Mahiuddin, L. Ryan, L. Su, and D. C. Christiani Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions Carcinogenesis, August 1, 2007; 28(8): 1697 - 1702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Liu, W. Zhou, B. Y. Yeap, L. Su, J. C. Wain, J. M. Poneros, N. S. Nishioka, T. J. Lynch, and D. C. Christiani XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk Carcinogenesis, June 1, 2007; 28(6): 1254 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Hu, L. Xu, M. Shao, J. Yuan, Y. Wang, F. Wang, W. Yuan, J. Qian, H. Ma, Y. Wang, et al. Polymorphisms in the Two Helicases ERCC2/XPD and ERCC3/XPB of the Transcription Factor IIH Complex and Risk of Lung Cancer: A Case-Control Analysis in a Chinese Population. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1336 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Mechanic, R. C. Millikan, J. Player, A. R. de Cotret, S. Winkel, K. Worley, K. Heard, K. Heard, C.-K. Tse, and T. Keku Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study Carcinogenesis, July 1, 2006; 27(7): 1377 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. de las Penas, M. Sanchez-Ronco, V. Alberola, M. Taron, C. Camps, R. Garcia-Carbonero, B. Massuti, C. Queralt, M. Botia, R. Garcia-Gomez, et al. Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients Ann. Onc., April 1, 2006; 17(4): 668 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wrensch, K. T. Kelsey, M. Liu, R. Miike, M. Moghadassi, J. D. Sison, K. Aldape, A. McMillan, J. Wiemels, and J. K. Wiencke ERCC1 and ERCC2 polymorphisms and adult glioma Neuro-oncol, October 1, 2005; 7(4): 495 - 507. [Abstract] [PDF]
|
|
|
|
|
|
S. W. Thurston, G. Liu, D. P. Miller, and D. C. Christiani Modeling Lung Cancer Risk in Case-Control Studies Using a New Dose Metric of Smoking Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2296 - 2302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Silva, O. M. Gil, V. C. Oliveira, M. N. Cabral, A. P. Azevedo, A. Faber, I. Manita, T. C. Ferreira, E. Limbert, J. E. Pina, et al. Association of Polymorphisms in ERCC2 Gene with Non-Familial Thyroid Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2407 - 2412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Casson, Z. Zheng, S. C. Evans, P. J. Veugelers, G. A. Porter, and D. L. Guernsey Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma Carcinogenesis, September 1, 2005; 26(9): 1536 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Broberg, J. Bjork, K. Paulsson, M. Hoglund, and M. Albin Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer Carcinogenesis, July 1, 2005; 26(7): 1263 - 1271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Han, G. A. Colditz, J. S. Liu, and D. J. Hunter Genetic Variation in XPD, Sun Exposure, and Risk of Skin Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1539 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Schabath, G. L. Delclos, H. B. Grossman, Y. Wang, S. P. Lerner, R. M. Chamberlain, M. R. Spitz, and X. Wu Polymorphisms in XPD Exons 10 and 23 and Bladder Cancer Risk Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 878 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Mechanic, A. J. Marrogi, J. A. Welsh, E. D. Bowman, M. A. Khan, L. Enewold, Y.-L. Zheng, S. Chanock, P. G. Shields, and C. C. Harris Polymorphisms in XPD and TP53 and mutation in human lung cancer Carcinogenesis, March 1, 2005; 26(3): 597 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhou, G. Liu, S. Park, Z. Wang, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani Gene-Smoking Interaction Associations for the ERCC1 Polymorphisms in the Risk of Lung Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 491 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Benhamou and A. Sarasin ERCC2 /XPD Gene Polymorphisms and Lung Cancer: A HuGE Review Am. J. Epidemiol., January 1, 2005; 161(1): 1 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Justenhoven, U. Hamann, B. Pesch, V. Harth, S. Rabstein, C. Baisch, C. Vollmert, T. Illig, Y.-D. Ko, T. Bruning, et al. ERCC2 Genotypes and a Corresponding Haplotype Are Linked with Breast Cancer Risk in a German Population Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2059 - 2064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-Q. He, J. E. Connett, N. R. Anthonisen, P. D. Pare, and A. J. Sandford Glutathione S-Transferase Variants and Their Interaction with Smoking on Lung Function Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 388 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Brewster, A. J. Alberg, P. T. Strickland, S. C. Hoffman, and K. Helzlsouer XPD Polymorphism and Risk of Subsequent Cancer in Individuals with Nonmelanoma Skin Cancer Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1271 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Isla, C. Sarries, R. Rosell, G. Alonso, M. Domine, M. Taron, G. Lopez-Vivanco, C. Camps, M. Botia, L. Nunez, et al. Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer Ann. Onc., August 1, 2004; 15(8): 1194 - 1203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ryan, W. Huang, S. W Thurston, K. T Kelsey, J. K Wiencke, and D. C Christiani On the use of biomarkers for environmental health research Statistical Methods in Medical Research, June 1, 2004; 13(3): 207 - 225. [Abstract] [PDF]
|
|
|
|
|
|
L. Hagmar, U. Stromberg, S. Bonassi, I.-L. Hansteen, L. E. Knudsen, C. Lindholm, and H. Norppa Impact of Types of Lymphocyte Chromosomal Aberrations on Human Cancer Risk: Results from Nordic and Italian Cohorts Cancer Res., March 15, 2004; 64(6): 2258 - 2263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Spitz, Q. Wei, Q. Dong, C. I. Amos, and X. Wu Genetic Susceptibility to Lung Cancer: The Role of DNA Damage and Repair Cancer Epidemiol. Biomarkers Prev., August 1, 2003; 12(8): 689 - 698. [Full Text] [PDF]
|
|
|
|
|
|
G. Matullo, M. Peluso, S. Polidoro, S. Guarrera, A. Munnia, V. Krogh, G. Masala, F. Berrino, S. Panico, R. Tumino, et al. Combination of DNA Repair Gene Single Nucleotide Polymorphisms and Increased Levels of DNA Adducts in a Population-based Study Cancer Epidemiol. Biomarkers Prev., July 1, 2003; 12(7): 674 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhou, G. Liu, D. P. Miller, S. W. Thurston, L. L. Xu, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani Polymorphisms in the DNA Repair Genes XRCC1 and ERCC2, Smoking, and Lung Cancer Risk Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 359 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Goode, C. M. Ulrich, and J. D. Potter Polymorphisms in DNA Repair Genes and Associations with Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1513 - 1530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Benhamou and A. Sarasin ERCC2/XPD gene polymorphisms and cancer risk Mutagenesis, November 1, 2002; 17(6): 463 - 469. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
